These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19498105)

  • 1. Pharmacological properties of 2-((R-5-chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a novel and selective alpha1A-adrenergic partial agonist, in in vitro and in vivo models of urethral function.
    Conlon K; Christy C; Westbrook S; Whitlock G; Roberts L; Stobie A; McMurray G
    J Pharmacol Exp Ther; 2009 Sep; 330(3):892-901. PubMed ID: 19498105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
    Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
    Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist.
    Altenbach RJ; Khilevich A; Kolasa T; Rohde JJ; Bhatia PA; Patel MV; Searle XB; Yang F; Bunnelle WH; Tietje K; Bayburt EK; Carroll WA; Meyer MD; Henry R; Buckner SA; Kuk J; Daza AV; Milicic IV; Cain JC; Kang CH; Ireland LM; Carr TL; Miller TR; Hancock AA; Nakane M; Esbenshade TA; Brune ME; O'Neill AB; Gauvin DM; Katwala SP; Holladay MW; Brioni JD; Sullivan JP
    J Med Chem; 2004 Jun; 47(12):3220-35. PubMed ID: 15163201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of A-204176, a novel and selective alpha1A adrenergic agonist, in in vitro and in vivo models of urethral function.
    O'Neill AB; Buckner SA; Brune ME; Milicic I; Daza AV; Gauvin DM; Altenbach RJ; Meyer MD; Williams M; Sullivan JP; Brioni JD
    Life Sci; 2001 Nov; 70(2):181-97. PubMed ID: 11787943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBx 6198: a novel alpha1-adrenoceptor antagonist for the treatment of benign prostatic hyperplasia.
    Nanda K; Naruganahalli KS; Gupta S; Malhotra S; Tiwari A; Hegde LG; Jain S; Sinha N; Gupta JB; Chugh A; Anand N; Ray A
    Eur J Pharmacol; 2009 Apr; 607(1-3):213-9. PubMed ID: 19239913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characteristics of Ro 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist: a potential therapy for stress urinary incontinence.
    Blue DR; Daniels DV; Gever JR; Jett MF; O'Yang C; Tang HM; Williams TJ; Ford AP
    BJU Int; 2004 Jan; 93(1):162-70. PubMed ID: 14678390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel 2-imidazoles as potent, selective and CNS penetrant alpha1A adrenoceptor partial agonists.
    Roberts LR; Bryans J; Conlon K; McMurray G; Stobie A; Whitlock GA
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6437-40. PubMed ID: 18980842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
    Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
    J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.
    Whitlock GA; Conlon K; McMurray G; Roberts LR; Stobie A; Thurlow RJ
    Bioorg Med Chem Lett; 2008 May; 18(9):2930-4. PubMed ID: 18400496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo pharmacological characterization of PF-01354082, a novel partial agonist selective for the 5-HT(4) receptor.
    Mikami T; Komada T; Sugimoto H; Suzuki K; Ohmi T; Kimura N; Naganeo R; Nakata E; Nakatani K; Toga T; Eda H; Sakakibara M
    Eur J Pharmacol; 2009 May; 609(1-3):5-12. PubMed ID: 19285067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent and selective alpha1A adrenoceptor partial agonists--novel imidazole frameworks.
    Whitlock GA; Brennan PE; Roberts LR; Stobie A
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3118-21. PubMed ID: 19394220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of alpha 1-adrenoceptor agonists in canine urethral pressure profilometry and abdominal leak point pressure models.
    Brune ME; O'Neill AB; Gauvin DM; Katwala SP; Altenbach RJ; Brioni JD; Hancock AA; Sullivan JP
    J Urol; 2001 Oct; 166(4):1555-9. PubMed ID: 11547130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6,7-Dihydro-5H-pyrrolo[1,2-a] imidazoles as potent and selective alpha1A adrenoceptor partial agonists.
    Roberts LR; Fish PV; Ian Storer R; Whitlock GA
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3113-7. PubMed ID: 19414260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the binding affinity of some newly synthesized phenylethanolamine and phenoxypropanolamine compounds at recombinant human beta- and alpha1-adrenoceptor subtypes.
    Ahmed M; Hanaoka Y; Kiso T; Kakita T; Ohtsubo Y; Muramatsu I; Nagatomo T
    J Pharm Pharmacol; 2005 Jan; 57(1):75-81. PubMed ID: 15638996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist pharmacology at recombinant α1A - and α1L -adrenoceptors and in lower urinary tract α1 -adrenoceptors.
    Yoshiki H; Uwada J; Umada H; Kobayashi T; Takahashi T; Yamakawa T; Yamaguchi A; Yokoyama O; Muramatsu I
    Br J Pharmacol; 2013 Nov; 170(6):1242-52. PubMed ID: 24024968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized crossover study to evaluate RO 115-1240, a selective alpha1A/1L-adrenoceptor partial agonist in women with stress urinary incontinence.
    Wein AJ
    BJU Int; 2004 Jun; 93(9):1361. PubMed ID: 15180647
    [No Abstract]   [Full Text] [Related]  

  • 18. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
    Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification and distribution of alpha1-adrenoceptor subtype mRNAs in human proximal urethra.
    Nasu K; Moriyama N; Fukasawa R; Tsujimoto G; Tanaka T; Yano J; Kawabe K
    Br J Pharmacol; 1998 Apr; 123(7):1289-93. PubMed ID: 9579721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity of oxymetazoline for urethral pressure vs blood pressure in the anaesthetized female rabbit.
    Modiri AR; Fredrickson MG; Gillberg PG; Alberts P
    Scand J Urol Nephrol; 2000 Jun; 34(3):151-6. PubMed ID: 10961466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.